Cyclo Therapeutics Inc (CYTH)
0.69
-0.01
(-1.29%)
USD |
NASDAQ |
Nov 22, 10:01
Cyclo Therapeutics Profit Margin (Quarterly): -3.78K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -3.78K% |
| June 30, 2024 | -4.86K% |
| March 31, 2024 | -2.15K% |
| December 31, 2023 | -1.81K% |
| September 30, 2023 | -963.0% |
| June 30, 2023 | -3.96K% |
| March 31, 2023 | -3.29K% |
| December 31, 2022 | -2.67K% |
| September 30, 2022 | -939.2% |
| June 30, 2022 | -637.0% |
| March 31, 2022 | -1.42K% |
| December 31, 2021 | -477.2% |
| September 30, 2021 | -955.7% |
| June 30, 2021 | -1.51K% |
| March 31, 2021 | -1.13K% |
| December 31, 2020 | -1.84K% |
| September 30, 2020 | -645.3% |
| June 30, 2020 | -1.05K% |
| March 31, 2020 | -808.6% |
| December 31, 2019 | -1.16K% |
| September 30, 2019 | -568.5% |
| June 30, 2019 | -500.9% |
| March 31, 2019 | -862.3% |
| December 31, 2018 | -570.1% |
| September 30, 2018 | -350.7% |
| Date | Value |
|---|---|
| June 30, 2018 | -369.0% |
| March 31, 2018 | -410.4% |
| December 31, 2017 | -821.6% |
| September 30, 2017 | -262.8% |
| June 30, 2017 | -158.2% |
| March 31, 2017 | -323.7% |
| December 31, 2016 | -157.7% |
| September 30, 2016 | -580.5% |
| June 30, 2016 | -278.7% |
| March 31, 2016 | -225.7% |
| December 31, 2015 | -650.4% |
| September 30, 2015 | -318.6% |
| June 30, 2015 | -94.70% |
| March 31, 2015 | -224.2% |
| December 31, 2014 | -71.13% |
| September 30, 2014 | -57.01% |
| June 30, 2014 | -87.24% |
| March 31, 2014 | 17.30% |
| December 31, 2013 | -36.02% |
| September 30, 2013 | -56.50% |
| June 30, 2013 | 37.23% |
| March 31, 2013 | 20.58% |
| December 31, 2012 | 43.90% |
| September 30, 2012 | -29.06% |
| June 30, 2012 | -38.08% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.86K%
Minimum
Jun 2024
-477.2%
Maximum
Dec 2021
-1.80K%
Average
-1.29K%
Median
Profit Margin (Quarterly) Benchmarks
| Stryker Corp | 15.18% |
| Biogen Inc | 15.76% |
| Pfizer Inc | 25.22% |
| Pacira BioSciences Inc | -85.11% |
| Moderna Inc | 0.70% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -344.6% |
| Return on Invested Capital | -20.42K% |
| Gross Profit Margin (Quarterly) | 92.81% |
| Operating Margin (Quarterly) | -3.55K% |
| Return on Net Operating Assets | -456.2% |